Standout Papers

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Pr... 2015 2026 2018 2022 360
  1. Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer (2019)
    Ronald de Wit, Johann S. de Bono et al. New England Journal of Medicine
  2. Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis (2015)
    Filippo Pietrantonio, Fausto Petrelli et al. European Journal of Cancer

Immediate Impact

4 by Nobel laureates 7 from Science/Nature 61 standout
Sub-graph 1 of 21

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
A pan-cancer analysis of the microbiome in metastatic cancer
2024 Standout
2 intermediate papers

Works of Roberto Iacovelli being referenced

Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma
2013

Author Peers

Author Last Decade Papers Cites
Roberto Iacovelli 2525 2022 1193 1499 221 4.4k
Fumio Imamura 3534 3060 1219 1822 205 5.8k
Dolores Isla 3002 2965 862 1445 198 5.0k
Hyojin Kim 1605 2111 955 1073 175 4.1k
Begoña Mellado 2130 1861 1118 1931 178 4.6k
Kazuko Sakai 2239 2680 1248 1969 238 5.3k
Akira Sakurada 3248 2511 838 1794 185 5.3k
Francesco Boccardo 1881 2796 2022 1273 265 6.2k
Neeraj Agarwal 3276 1566 1358 1829 203 4.7k
Stephan Störkel 3636 1518 1416 2887 122 5.7k
Shin Egawa 3623 1256 1181 1614 355 6.2k

All Works

Loading papers...

Rankless by CCL
2026